Oral hedgehog-pathway inhibitors for basal-cell carcinoma
- PMID: 22670909
- DOI: 10.1056/NEJMe1202170
Oral hedgehog-pathway inhibitors for basal-cell carcinoma
Comment in
-
Vismodegib in advanced basal-cell carcinoma.N Engl J Med. 2012 Sep 6;367(10):970; author reply 970-1. doi: 10.1056/NEJMc1208003. N Engl J Med. 2012. PMID: 22931271 No abstract available.
Comment on
-
Efficacy and safety of vismodegib in advanced basal-cell carcinoma.N Engl J Med. 2012 Jun 7;366(23):2171-9. doi: 10.1056/NEJMoa1113713. N Engl J Med. 2012. PMID: 22670903 Free PMC article. Clinical Trial.
-
Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome.N Engl J Med. 2012 Jun 7;366(23):2180-8. doi: 10.1056/NEJMoa1113538. N Engl J Med. 2012. PMID: 22670904 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical